The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Medical Devices
Jafron Biomedical Price, Forecast, Insider, Ratings, Fundamentals & Signals
6.79% CNY29.41
America/New_York / 6 mai 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 23 037 mill |
| EPS: | 0.660 |
| P/E: | 44.56 |
| Earnings Date: | May 20, 2024 |
| SharesOutstanding: | 783.31 mill |
| Avg Daily Volume: | 7.82 mill |
| RATING 2024-05-06 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.24x |
| Company: PE 44.56 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.09x |
| Company: PE 44.56 | industry: PE 40.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY30.38 (3.30%) CNY0.970 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 28.04 - 29.84 ( +/- 3.10%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY29.41 (6.79% ) |
| Volume | 23.18 mill |
| Avg. Vol. | 7.82 mill |
| % of Avg. Vol | 296.50 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 300529.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
300529.SZ
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.